Home » Genzyme, Takeda May Be in Talks
Genzyme, Takeda May Be in Talks
Cambridge-based Genzyme Corp. has started talks with Takeda Pharmaceutical Co. in a move to try to sell itself for more than $18.5 billion, the Mail reported, citing a person familiar with the matter.
boston
boston
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May